_version_ 1785091026906513408
author Tucci, Francesca
Consiglieri, Giulia
Filisetti, Chiara
De Pellegrin, Maurizio
Mellone, Renata
Fumagalli, Francesca
Darin, Silvia
Sarzana, Marina
Scarparo, Stefano
Ciotti, Francesca
Silvani, Paolo
Baldoli, Cristina
Pontesilli, Silvia
Parini, Rossella
la Marca, Giancarlo
Ciceri, Fabio
Naldini, Luigi
Aiuti, Alessandro
Gentner, Bernhard
Ester Bernardo, Maria
author_facet Tucci, Francesca
Consiglieri, Giulia
Filisetti, Chiara
De Pellegrin, Maurizio
Mellone, Renata
Fumagalli, Francesca
Darin, Silvia
Sarzana, Marina
Scarparo, Stefano
Ciotti, Francesca
Silvani, Paolo
Baldoli, Cristina
Pontesilli, Silvia
Parini, Rossella
la Marca, Giancarlo
Ciceri, Fabio
Naldini, Luigi
Aiuti, Alessandro
Gentner, Bernhard
Ester Bernardo, Maria
author_sort Tucci, Francesca
collection PubMed
description
format Online
Article
Text
id pubmed-10430690
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104306902023-08-17 P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP Tucci, Francesca Consiglieri, Giulia Filisetti, Chiara De Pellegrin, Maurizio Mellone, Renata Fumagalli, Francesca Darin, Silvia Sarzana, Marina Scarparo, Stefano Ciotti, Francesca Silvani, Paolo Baldoli, Cristina Pontesilli, Silvia Parini, Rossella la Marca, Giancarlo Ciceri, Fabio Naldini, Luigi Aiuti, Alessandro Gentner, Bernhard Ester Bernardo, Maria Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430690/ http://dx.doi.org/10.1097/01.HS9.0000972456.19958.59 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Tucci, Francesca
Consiglieri, Giulia
Filisetti, Chiara
De Pellegrin, Maurizio
Mellone, Renata
Fumagalli, Francesca
Darin, Silvia
Sarzana, Marina
Scarparo, Stefano
Ciotti, Francesca
Silvani, Paolo
Baldoli, Cristina
Pontesilli, Silvia
Parini, Rossella
la Marca, Giancarlo
Ciceri, Fabio
Naldini, Luigi
Aiuti, Alessandro
Gentner, Bernhard
Ester Bernardo, Maria
P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
title P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
title_full P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
title_fullStr P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
title_full_unstemmed P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
title_short P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
title_sort p1392: interim analysis of first in human phase i-ii clinical trial of ex-vivo gene therapy for hurler syndrome: an update at 3 year follow-up
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430690/
http://dx.doi.org/10.1097/01.HS9.0000972456.19958.59
work_keys_str_mv AT tuccifrancesca p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT consiglierigiulia p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT filisettichiara p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT depellegrinmaurizio p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT mellonerenata p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT fumagallifrancesca p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT darinsilvia p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT sarzanamarina p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT scarparostefano p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT ciottifrancesca p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT silvanipaolo p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT baldolicristina p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT pontesillisilvia p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT parinirossella p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT lamarcagiancarlo p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT cicerifabio p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT naldiniluigi p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT aiutialessandro p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT gentnerbernhard p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup
AT esterbernardomaria p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup